No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Global In-vitro Fertilization Microscopes Market Anticipated to Garner $250.4 Million, Growing at a 9.4% CAGR in the 2022-2031 Timeframe | Defined by Research Dive

Editor: What To Know

  • Europe – Significant market share in 2021The presence of a large population, improved awareness about IVF, and the availability of IVF services in this region are predicted to propel the regional market growth in the forecast period.
  • Apart from the information summarized in this press release, the final report covers crucial aspects of the market including SWOT analysis, market overview, Porter’s five forces analysis, market dynamics, segmentation (key market trends, forecast analysis, and regional analysis), and company profiles (company overview, operating business segments, product portfolio, financial performance, and latest strategic moves and developments.
  • Embryo Microscope – Most profitable in 2021The rising importance of embryo microscope to take photos of embryos developed during in-vitro fertilization cycles in an incubator is expected to propel the sub-segment forward.

Global In-vitro Fertilization Microscopes Market Forecast Analysis:

As per the report published by Research Dive, the global in-vitro fertilization microscopes market is expected to register a revenue of $250.4 million by 2031 and grow at a CAGR of 9.4% during the forecast period 2022-2031.

Segments of the In-vitro Fertilization Microscopes Market

The report has divided the in-vitro fertilization microscopes market into the following segments:

  • Type: upright microscope, inverted microscope, stereo microscope, and embryo microscope
    • Embryo Microscope Most profitable in 2021
      The rising importance of embryo microscope to take photos of embryos developed during in-vitro fertilization cycles in an incubator is expected to propel the sub-segment forward.
  • End user: clinical and academic research
    • Clinical – Most lucrative in 2021
      IVF clinics provide a range of services, such as identifying healthy oocytes, ICSI, sperm analysis, embryo monitoring, and freezing and storing of embryos, which is anticipated to push the sub-segment forward.
  • Region: North America, Europe, Asia-Pacific, and LAMEA
    • Europe Significant market share in 2021
      The presence of a large population, improved awareness about IVF, and the availability of IVF services in this region are predicted to propel the regional market growth in the forecast period.

To get access to the Complete PDF Sample of In-vitro Fertilization Microscopes Market Click Here!

Dynamics of the Global In-vitro Fertilization Microscopes Market

Increased public awareness of in-vitro fertilization is expected to make the in-vitro fertilization microscopes market a highly profitable one in the forecast period. Additionally, the growing success rate of in-vitro fertilization techniques and the accessibility of financial resources are predicted to propel the market forward. However, the high price and risks of IVF and ICSI treatments might become a restraint in the growth of the market.

The increased focus on regenerative medicine and nanotechnology research is predicted to offer numerous growth opportunities to the market in the forecast period. Moreover, rising treatment effectiveness as a result of product innovations is expected to propel the in-vitro fertilization microscopes market forward in the coming period.

COVID-19 Impact on the Global In-vitro Fertilization Microscopes Market

The COVID-19 pandemic disrupted the routine lifestyle of people across the globe and the subsequent lockdowns adversely impacted the industrial processes across all sectors. The in-vitro fertilization microscopes market, too, was negatively impacted due to the pandemic. This ultimately reduced demand for microscopes due to supply chain interruptions, the closure of manufacturing companies, and a global economic downturn. In addition, nations that manufacture a significant number of microscopes, including the U.S. and China, were subject to import-export restrictions. These factors significantly hindered the market growth amidst the pandemic.

Check out COVID-19 Impact on In-vitro Fertilization Microscopes Market. Connect with an Expert Analyst or Schedule a call

Key Players of the Global In-vitro Fertilization Microscopes Market

The major players of the market include

  • Olympus Corporation
  • Linkam Scientific Instruments
  • Leica Microsystems
  • Zeiss
  • Euromex Microscopen B.V.
  • Meiji Techno
  • Labomed Europe B.V.
  • Nikon Corporation
  • Eppendorf AG
  • Narishige Group
  • Hamilton Thorne Ltd.

These players are working on developing strategies such as product development, merger and acquisition, partnerships, and collaborations to sustain the market growth.

For instance, in August 2021, Nikon Microscopes, a specialist in microscope-based optical and imaging technology for the life sciences and a member of Nikon Healthcare Business Division, announced ECLIPSE Ti2-U IVF for the primary intracytoplasmic sperm injection (ICSI) treatments.

Request Customization of In-vitro Fertilization Microscopes Market Report as per your Definition and Format & Avail of Amazing Discount

What the Report Covers

Apart from the information summarized in this press release, the final report covers crucial aspects of the market including SWOT analysis, market overview, Porter’s five forces analysis, market dynamics, segmentation (key market trends, forecast analysis, and regional analysis), and company profiles (company overview, operating business segments, product portfolio, financial performance, and latest strategic moves and developments.)

More about In-vitro Fertilization Microscopes Market:

Some Trending Reports:

About Research Dive

Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With an unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy